In a human model of hepatocellular carcinoma, pterostilbene suppresses tumor growth by interfering in the signal transduction pathways of NF-κB and on the expression of VEGF, matrix metalloproteinase-9 (MMP-9), AP-1 and mitogen-activated protein kinase (MAPK) [34,35]. This evidence concerns the gene MMP9 and neoplasm.